Round 1 Winners!
Proof of Usefulness Report

Really

Analysis completed on 3/24/2026

+31.35
Proof of Usefulness Score
You're In Business

The project addresses a critical real-world problem (early detection of Alzheimer's via linguistic biomarkers) and has a strong theoretical utility. However, the submission contains significant inconsistencies and red flags. Claims such as 'most people have used my product' are unsubstantiated and highly improbable. Furthermore, maintaining a 125-person team since 2016 with only a $2.5M 'all time marketcap' presents severe mathematical contradictions. The lack of specific technical details and vague traction metrics result in severe penalties across audience reach, evidence of traction, and response quality.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+20.00
Audience Reach Impact+1.00
Technical Innovation+5.25
Evidence Of Traction+1.25
Market Timing Relevance+5.00
Functional Completeness+0.50
Subtotal+33
Usefulness Multiplierx0.95
Final Score+31

Project Details

Project URL
Description
At Really, our vision is simple and ambitious - A world that no longer suffers from Alzheimer’s. Vision By better understanding language, and how our use of it changes over time, we at Really hope to detect Alzheimer’s and other forms of neurodegeneration some 20 years earlier than currently possible. We hope to improve all aspects of the therapeutic lifecycle: improve research by finding the best clinical trial candidates, improve therapies from the fact that we act much earlier and compress the product life cycle of drug discovery and development. We want to improve life outcomes by affording treatments the highest potential to succeed. Tech We ingest all forms of written language (email, SMS, social media, etc.), construct a baseline of an individual’s mental state from derived linguistic biomarkers, and monitor, passively and non-invasively for neurodegeneration over time. We are building our Machine Learning and Artificial Intelligence engine from collaboration with leading partners in this space. Team An experienced team from startup, corporate, tech, people, branding, AI and growth business backgrounds - augmented by a well established, industry leading team of advisors, representing the broader machine learning and MedTech ecosystems.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline